Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular complications, lagophthalmos, and dry eye in preseptal versus pretarsal botulinum toxin injection in benign essential blepharospasm
TCTR20190807005Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of neuronox in idiopathic blepharospasm (BEB) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
neuronox
03
Conditions
idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on TCTR20190807005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190807005.